We Need a Miracle: How Drug R&D Needs to Change to Cure Disease

Healthcare digitization is booming and data-driven innovations are disrupting drug discovery. But we must learn how to use these emerging technologies better so that we can ask more sophisticated questions, and come up with deeper insights into biology and the understanding and treatment of disease. David Shaywitz talks about disruptive innovators and offers some sober views on how hard it is to re-invent drug R&D.

Om Podcasten

Under the DataScope: A six-episode podcast series from the Kraft Precision Medicine Accelerator at Harvard Business School, showcasing the most important companies—their innovations and their progress—that bring data and analytics technologies to precision medicine today. Discussions focus on the business models, technologies, and proof points of data and analytics leaders to illuminate the richness of this landscape today and its fast-paced future progress. Guests include: • John Wilbanks - Chief Commons Officer, Sage Bionetworks • David Shaywitz - Senior Partner, Takeda Ventures • Jeff Elton – CEO, Concerto Health AI • Wout Brusselaers – Founder/CEO, Deep6 • Richard Williams - Managing Director & CMO, Wuxi NextCode • Eyal Gura - Founder/CEO, Zebra Medical Vision